|
|
||||||||
EDUCATION EXHIBIT |
1 From the Department of Radiology and Center for Imaging Science (K.S.L., Y.J.J.), the Department of Diagnostic Pathology (J.H.), the Department of Nuclear Medicine (B.T.K.), and the Division of Pulmonary and Critical Care Medicine, Department of Medicine (H.K., O.J.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135710, Korea. Presented as an education exhibit at the 2003 RSNA scientific assembly. Received February 13, 2004; revision requested March 26; final revision received April 19; accepted April 19. Supported in part by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (00-PJ1-PG1-CY030001). All authors have no financial relationships to disclose. Address correspondence to K.S.L. (e-mail: melon2@samsung.co.kr).
About 5% of T1 nonsmall cell lung cancers (ie, lung cancers less than 3 cm in diameter), mostly focal nodular bronchioloalveolar carcinomas and carcinoid tumors, demonstrate no uptake at fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and appear to be indolent in growth; consequently, they are associated with long-term patient survival. About 21% of T1 lung cancers show mediastinal nodal metastasis at the time of diagnosis and about 24% show extrathoracic metastasis, mostly brain metastasis, either at the time of diagnosis or at 1-year follow-up. T1 lung cancers with a large ground-glass attenuation component (50% of tumor volume) at thin-section computed tomography (CT) have a good prognosis with less likelihood of mediastinal nodal or extrathoracic metastasis. On the other hand, solid cancer lesions, especially those with a spiculated margin or with bronchovascular bundle thickening in the surrounding lung, more frequently demonstrate local vessel invasion, lymph node metastasis, and extrathoracic metastasis. In these tumors, work-up for extrathoracic metastases (including whole-body FDG PET or brain magnetic resonance imaging and mediastinoscopy for mediastinal nodes) may be needed, even when CT demonstrates no enlarged nodes in the mediastinum.
© RSNA, 2004
Index Terms: Lung neoplasms, 60.321 Lung neoplasms, CT, 60.1211 Lung neoplasms, diagnosis Lung neoplasms, PET, 60.12163 Lung neoplasms, screening, 60.1211, 60.12163 Lung neoplasms, staging
Related Article
RadioGraphics 2004 24: 1632-1636.
This article has been cited by other articles:
![]() |
D. Arenberg Bronchioloalveolar Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 306S - 313S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Jeong, C. A. Yi, and K. S. Lee Solitary Pulmonary Nodules: Detection, Characterization, and Guidance for Further Diagnostic Workup and Treatment Am. J. Roentgenol., January 1, 2007; 188(1): 57 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shim, K. S. Lee, M. J. Chung, H. Kim, O J. Kwon, and S. Kim Do hemodynamic studies of stage t1 lung cancer enable the prediction of hilar or mediastinal nodal metastasis? Am. J. Roentgenol., April 1, 2006; 186(4): 981 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shim, K. S. Lee, B.-T. Kim, J. Y. Choi, M. J. Chung, and E. J. Lee Focal Parenchymal Lung Lesions Showing a Potential of False-Positive and False-Negative Interpretations on Integrated PET/CT. Am. J. Roentgenol., March 1, 2006; 186(3): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Port, R. S. Andrade, M. A. Levin, R. J. Korst, P. C. Lee, D. E. Becker, and N. K. Altorki Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1611 - 1615. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |